P-202Preclinical assessment of the bioequivalence of branded and generic oxaliplatin and incidence of hypersensitivity reactions in patients with advanced colorectal cancer

C. Baratelli; C. Sonetto; S. Benedetto; E. Rubatto; F. Di Scipio; E. Pirro; P. Brizzi Maria; M. Di Maio; N. Berta Giovanni; V. Scagliotti Giorgio; M. Tampellini

doi:10.1093/annonc/mdw199.194

P-202Preclinical assessment of the bioequivalence of branded and generic oxaliplatin and incidence of hypersensitivity reactions in patients with advanced colorectal cancer

By C. Baratelli, C. Sonetto, S. Benedetto, E. Rubatto, F. Di Scipio, E. Pirro, P. Brizzi Maria, M. Di Maio, N. Berta Giovanni, V. Scagliotti Giorgio and M. Tampellini

Publisher: Oxford University Press (OUP)

Year: 2016

DOI identifier: 10.1093/annonc/mdw199.194

OAI identifier:

Provided by: MUCC (Crossref)

Download PDF:
_{Sorry, we are unable to provide the full text but you may find it at the
following location(s):}

http://europepmc.org/articles/... (external link)

P-202Preclinical assessment of the bioequivalence of branded and generic oxaliplatin and incidence of hypersensitivity reactions in patients with advanced colorectal cancer

Suggested articles